Synlife is a R&D-stage biotech startup innovating the next generation of therapeutics through the bottom-up engineering of Synthetic Cells.

Synthetic Cells are liposomes (tiny membrane-bound vesicles) that contain systems of molecules that endow salient features of a living cell, such as metabolism.

We have engineered Synthetic Cells that contain systems of highly active enzymes that together compose a metabolic pathway. When deployed as therapeutics, these Synthetic Cells could temporarily augment metabolism throughout or at targeted sites in the body.